Clinical Trial Update: Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing oral and intravenous esomeprazole on basal and pentagastrin-stimulated acid output in subjects with gastroesophageal reflux dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED